Key result
PPARalpha activation by fibrates reduces the macrophage cholesteryl ester-to-free cholesterol ratio and lowers ACAT1 activity.
Answers are grounded in this paper and cite their sources.
Peroxisome proliferator-activated receptor alpha (PPARalpha) is a nuclear receptor activated by fatty acid derivatives and hypolipidemic drugs of the fibrate class. PPARalpha is expressed in monocytes, macrophages, and foam cells, suggesting a role for this receptor in macrophage lipid homeostasis with consequences for atherosclerosis development. Recently, it was shown that PPARalpha activation promotes cholesterol efflux from macrophages via induction of the ABCA1 pathway. In the present study, the influence of PPARalpha activators on intracellular cholesterol homeostasis was investigated. In human macrophages and foam cells, treatment with fibrates, synthetic PPARalpha activators, led to a decrease in the cholesteryl ester (CE):free cholesterol (FC) ratio. In these cells, PPARalpha activation reduced cholesterol esterification rates and Acyl-CoA:cholesterol acyltransferase-1 (ACAT1) activity. However, PPARalpha activation did not alter ACAT1 gene expression, whereas mRNA levels of carnitine palmitoyltransferase type 1 (CPT-1), a key enzyme in mitochondrial fatty acid catabolism, were induced. Finally, PPARalpha activation blocked CE formation induced by TNF-alpha, possibly due to the inhibition of neutral sphingomyelinase activation by TNF-alpha. In conclusion, our results identify a role for PPARalpha in the control of cholesterol esterification in macrophages, resulting in an enhanced availability of FC for efflux through the ABCA1 pathway.
No takes yet. Share an insight, caveat, or question.
Chinetti et al. (2003) studied Atherosclerosis / macrophage lipid homeostasis. Fibrates (synthetic PPARalpha activators) was evaluated on Cholesteryl ester (CE):free cholesterol (FC) ratio, cholesterol esterification rates, and ACAT1 activity. Fibrate-mediated PPARalpha activation in human macrophages and foam cells decreased the cholesteryl ester to free cholesterol ratio and reduced ACAT1 activity.
Synapse has enriched 10 related papers. Consider them for comparative context: